stars 1 stars 2 stars 3

Be Clinic Ready! Corealis Pharma provides services on a contract basis in the areas of Formulation & Process Development as well as in small scale Clinical Trial Material (Phase I and II) Manufacturing and the packaging of solid dosage forms (tablets & capsules) to pharmaceutical and biotech companies. Our services include: API characterization; salt selection; pre-formulation; formulation & process development; analytical method development; stability storage & testing; technical transfer and scale-up; cGMP manufacturing & packaging of Phase I and II CTM; dossier support for American, European, and Canadian submissions. Our experts have access to modern well equipped R&D and cGMP manufacturing & packaging facilities that allow them to successfully complete the most challenging and complex mandates. The primary objective of Corealis and its staff is to make every one of their customers succeed. Corealis Pharma Inc. offers personalized and efficient services in the areas of Formulation Development and Clinical Supply Manufacturing of solid oral dosage forms.

Corealis Pharma Inc. Questions

The Corealis Pharma Inc. annual revenue was $13.5 million in 2026.

Patrick Frankham is the Vice President of Business Development of Corealis Pharma Inc..

34 people are employed at Corealis Pharma Inc..

Corealis Pharma Inc. is based in Laval, Quebec.

The NAICS codes for Corealis Pharma Inc. are [325, 32, 3254, 32541].

The SIC codes for Corealis Pharma Inc. are [28, 283].

Top Corealis Pharma Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users